| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |